Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
4. What type of surgery is indicated? Operative findings: • 3 x 2 cm ulcer of the lower gingiva with invasion into the mandible • 5 x 4 cm well-encapsulated firm mass located at the submandibular triangle (level 1 to level 2 ) • Multiple pinkish-red, firm, grossly enlarged nodes (1-2 cm) along the jugular chain (levels 2 to 4) • 4 x 3 cm well encapsulated firm mass at the subclavicular area TNM Staging T N M Stage IVC Operation done • Wide excision of the ulcer with segmental mandibulectomy with modified radical neck dissection, left: the defect was reconstructed using titanium plates. Segmental Mandibulectomy • removes an entire segment of the mandible, disrupting continuity of the bone. This is performed when tumor invades bone. • may be performed in the setting of a composite resection, – resection of a segment of mandible in continuity with a cancer of the oral cavity or oropharynx or a primary cancer of the alveolar ridge. http://www.expertconsultbook.com/expertconsult/ob/book.do?method=display&typ e=bookPage&decorator=none&eid=4-u1.0-B978-1-4160-2445-3..500376&isbn=978-1-4160-2445-3 • Advantages – Adequate margins of resection – Excellent exposure – Ease of exposure • Disadvantages • Cosmetic and functional consequences Final histopath: • Well differentiated squamous cell carcinoma with metastasis to 5/20 lymph nodes, the largest measures 2 cm with extracapsular invasion; margins clear; with bony invasion 5. What adjuvant treatment is required Radiation • Pre and post-op radiation – Improves local/regional control in HNSCC – within 6 weeks of surgery – 50 to 70 Gy over 5 to 7 weeks • Adverse reactions: – acute: mucositis, skin erythema – Late: fibrosis, xerostomia, altered state Chemotherapy • No survival advantage compared to surgery and/or radiation – Cisplatin, carboplatin, 5-FU • Palliation of recurrent or unresectable disease, combined with radiation